Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 1982BloodOpen Access

Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes

View Full Paper
Ask AI
Bookmark
Share

Authors

ZRZM RuggeriScripps Research InstitutePMPM MannucciFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoRLR LombardiUniversity of Milan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ruggeri et al. (1982) studied this question.

synapsesocial.com/papers/6a08ac63df3db8739810afbchttps://doi.org/10.1182/blood.v59.6.1272.1272
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inherited Variants of Factor-VIII-Related Protein in von Willebrand's Disease1974 · 134 citations
  2. 2The Release of Plasminogen Activator and Factor VIII after Injection of DDAVP in Healthy Volunteers and in Patients with von Willebrand's Disease1980 · 69 citations
  3. 3Von willebrand disease with an increased ristocetin‐induced platelet aggregation and a qualitative abnormality of the factor VIII protein1980 · 33 citations
  4. 4The factor VIII complex: structure and function1981 · 403 citations
  5. 5Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs1975 · 397 citations